SCHEMBL6169399

SCHEMBL6169399

CCC(=O)/C(=C/c1ccccc1)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 3/20 0.63
MAPT P10636 5/20 0.55
LMNA P02545 3/20 0.55
HTT P42858 3/20 0.55
NPSR1 Q6W5P4 3/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C9 P11712 2/20 0.55
CYP2C19 P33261 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP3A4 P08684 1/20 0.55
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
HPGD P15428 4/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
POLB P06746 1/20 0.54
MAPK1 P28482 1/20 0.54
AKR1C2 P52895 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169402 1.00 AKR1C1 (0.63) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL6170751 0.86 AKR1C3 (0.64) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL6170757 0.86 AKR1C3 (0.64) AKR1C1MAPTLMNAHTTNPSR1
Alcohol SCHEMBL27937505 0.81 AKR1C1 (0.81) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL11881810 0.81 CES1 (0.59) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL2037146 0.81 CES1 (0.59) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL15664806 0.80 MEN1 (0.55) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL15664807 0.80 MEN1 (0.55) AKR1C1MAPTLMNAHTTNPSR1
SCHEMBL8038875 0.80 MEN1 (0.63) AKR1C1LMNAHTTCYP2C9CYP3A4
SCHEMBL11219398 0.80 AKR1C1 (0.73) AKR1C1MAPTLMNAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-58150533-A None JP disclosed
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
JP-S58150533-A PREPARATION OF ALPHA,BETA-UNSATURATED KETONE RIKAGAKU KENKYUSHO 1983-09-07 JP disclosed